Healthcare Innovation September 5, 2024
David Raths

The iPATH trial will test the implementation of a practice transformation strategy for patients with type 2 diabetes in FQHCs in California, Massachusetts, Ohio, and Puerto Rico

The iPATH trial, one of the newest additions to the NIH Collaboratory Trials portfolio, is testing the implementation of a practice transformation strategy for patients with type 2 diabetes in federally qualified health centers (FQHCs) in California, Massachusetts, Ohio, and Puerto Rico.

In the iPATH (Implementing Scalable, Patient-Centered Team-Based Care for Adults With Type 2 Diabetes and Health Disparities) project, a network of research teams from Stanford, Harvard, the Ohio State University, and Impactivo LLC is working to refine and implement an an approach to practice transformation originally conceived to support FQHCs’ pursuit...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Health System / Hospital, Provider, Trends
Are Medicare Fee Schedules Appropriate For Commercial Populations?
Critical Condition: How To Protect The Healthcare Industry From Increasingly Frequent—And Harmful—Cyberattacks
Coalition releases 2024 year-end report
Optimizing the Revenue Cycle Can be Financial Game Changer, KLAS Report Finds
Mount Sinai's grand AI venture

Share This Article